Menu
Recruiting NCT05390424

Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot

No phase Interventional Hepatitis B Hepatitis C AIDS

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Blood collection using Dried Blood Spot.
Who it may be relevant to
Registry conditions: Hepatitis B, Hepatitis C, AIDS. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The aim of the study is to screen for hepatitis B, hepatitis C and AIDS viruses using a Dried Blood Spot in drug users

Interventions

  • Diagnostic test Blood collection using Dried Blood Spot
    Drug users will be screened for Hepatitis C, Hepatitis B and AIDS using Dried Blood Spot for blood collection

Primary outcome measures

  • Number of person with an active hepatitis C infection [Time frame: Day 1]
  • Number of person with an active hepatitis B infection [Time frame: Day 1]
  • Number of person with an active AIDS infection [Time frame: Day 1]

Eligibility criteria

Inclusion criteria

  • Former or active intravenous and/or nasal drug user
  • Person on opiate substitution therapy

Exclusion criteria

  • Person with known active viral infection(s)

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Diagnostic

Study locations

France · 11 centers
  • Caarud Sud Manche — Avranches
  • Csapa Barentin — Barentin
  • Oeuvre Normande Des Meres — Dieppe
  • Csapa Act — Elbeuf
  • Csapa Gisors — Gisors
  • Csapa Nautilia — Le Havre
  • Csapa Pont-Audemer — Pont-Audemer
  • Aides Region Normandie — Rouen
  • … and 3 more centers

Identifiers

NCT: NCT05390424 · 2021/0098/HP

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗